Contact
searchSearch
HMP Global

June 2017 - FRMC

Department

Conference Insider
Novel Treatments and Strategies For Relapsing Multiple Sclerosis
07/06/2017
Gary Owens, MD, a managed health care consultant and a First Report Managed Care Editorial Advisory Board member, presented “Improving Patient Outcomes with Novel Treatments and Strategies in the Management of Relapsing Multiple Sclerosis,”...
Gary Owens, MD, a managed health care consultant and a First Report Managed Care Editorial Advisory Board member, presented “Improving Patient Outcomes with Novel Treatments and Strategies in the Management of Relapsing Multiple Sclerosis,”...
Gary Owens, MD, a managed health...
07/06/2017
First Report Managed Care
Conference Insider
Improving Management of Patients with Psoriasis to Reduce Costs
07/06/2017
Steven R Feldman, MD, PhD, professor of dermatology at the Psoriasis Treatment Center at Wake Forest University School of Medicine, discussed how to improve treatment adherence and outcomes in patients with psoriasis at the NAMCP 2017 Spring...
Steven R Feldman, MD, PhD, professor of dermatology at the Psoriasis Treatment Center at Wake Forest University School of Medicine, discussed how to improve treatment adherence and outcomes in patients with psoriasis at the NAMCP 2017 Spring...
Steven R Feldman, MD, PhD,...
07/06/2017
First Report Managed Care
Conference Insider
Targeted QI Initiative Improves CRC Screening Uptake
07/06/2017
A quality improvement initiative using fecal immunochemical testing (FIT) and colonoscopy was able to improve colorectal cancer (CRC) screening uptake in a managed care setting, according to a poster presented at Digestive Disease Week 2017.
A quality improvement initiative using fecal immunochemical testing (FIT) and colonoscopy was able to improve colorectal cancer (CRC) screening uptake in a managed care setting, according to a poster presented at Digestive Disease Week 2017.
A quality improvement initiative...
07/06/2017
First Report Managed Care
Conference Insider
Switching From Remicade to Biosimilar Inflectra Effective For IBD
07/06/2017
Research presented at Digestive Disease Week 2017 found that switching from Remicade (infliximab; Janssen) to Inflectra (infliximab-dyyb; Pfizer) did not cause inflammatory bowel disease (IBD) symptoms to evolve among a patient cohort in...
Research presented at Digestive Disease Week 2017 found that switching from Remicade (infliximab; Janssen) to Inflectra (infliximab-dyyb; Pfizer) did not cause inflammatory bowel disease (IBD) symptoms to evolve among a patient cohort in...
Research presented at Digestive...
07/06/2017
First Report Managed Care
Conference Insider
Integrated Care Model Improved Outcomes Patients With IBD
07/06/2017
A recent presentation at Digestive Disease Week 2017 showed that integrated models of care improve management and outcomes of inflammatory bowel diseases like Crohn disease and ulcerative colitis.
A recent presentation at Digestive Disease Week 2017 showed that integrated models of care improve management and outcomes of inflammatory bowel diseases like Crohn disease and ulcerative colitis.
A recent presentation at...
07/06/2017
First Report Managed Care
Conference Insider
Trulance Reduced Symptom Severity in Patients With Irritable Bowel Syndrome
07/06/2017
Recent research from two phase 3 clinical trials, presented at Digestive Disease Week 2017, showed that Trulance (plecanatide; Synergy) is safe and effective at reducing symptom severity in patients with irritable bowel syndrome (IBS) with...
Recent research from two phase 3 clinical trials, presented at Digestive Disease Week 2017, showed that Trulance (plecanatide; Synergy) is safe and effective at reducing symptom severity in patients with irritable bowel syndrome (IBS) with...
Recent research from two phase 3...
07/06/2017
First Report Managed Care
Conference Insider
Costs, Hospital Stay Reduced Through Nonsurgical Weight-Loss Treatment Option
07/06/2017
A study presented at Digestive Disease Week 2017 found that nonsurgical endoscopic sleeve gastroplasty may be an effective option for treating obesity in patients who are not candidates for surgery. 
A study presented at Digestive Disease Week 2017 found that nonsurgical endoscopic sleeve gastroplasty may be an effective option for treating obesity in patients who are not candidates for surgery. 
A study presented at Digestive...
07/06/2017
First Report Managed Care
Conference Insider
Financial Conflicts of Interest Common Among Clinical Pathway Vendors
07/06/2017
A majority of practitioners involved in clinical pathway development at three major oncology vendors received nonresearch general payments in 2015, according to research presented at the 2017 ASCO Annual Meeting.
A majority of practitioners involved in clinical pathway development at three major oncology vendors received nonresearch general payments in 2015, according to research presented at the 2017 ASCO Annual Meeting.
A majority of practitioners...
07/06/2017
First Report Managed Care
Conference Insider
Cancer Drug Costs Are Too High Relative to Clinical Value
07/06/2017
A recent poster presentation at the 2017 ASCO Annual Meeting found that the clinical value of new oncology drugs is not in line with high price increases over time. 
A recent poster presentation at the 2017 ASCO Annual Meeting found that the clinical value of new oncology drugs is not in line with high price increases over time. 
A recent poster presentation at...
07/06/2017
First Report Managed Care
Conference Insider
ACA Increased Cancer Screenings, Early Diagnosis
07/06/2017
Recent research presented at the 2017 ASCO Annual Meeting found that after implementation of the ACA, there was a slight increase in the percentage of cancers diagnosed at an earlier, more treatable stage.
Recent research presented at the 2017 ASCO Annual Meeting found that after implementation of the ACA, there was a slight increase in the percentage of cancers diagnosed at an earlier, more treatable stage.
Recent research presented at the...
07/06/2017
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

Headshot of Gary Owens
Interview
An Overview of Vitiligo: Prevalence, Comorbidities, and Available Therapies
05/30/2023
Maria Asimopoulos
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of...
05/30/2023
First Report Managed Care
News
Substantial Annual Health Care Costs Associated With Hemophilia A
06/23/2023
Julie Gould
Researchers conducted a comprehensive literature review to investigate the direct and indirect costs associated with hemophilia A.
Researchers conducted a comprehensive literature review to investigate the direct and indirect costs associated with hemophilia A.
Researchers conducted a...
06/23/2023
First Report Managed Care
News
RSV Vaccination in US Older Adults Could Save Up to $1 Billion Per Season
07/24/2023
Jolynn Tumolo
"Our analysis provides contemporary estimates of the population-level RSV disease burden and insights into the economic value drivers for RSV vaccination," said researchers. 
"Our analysis provides contemporary estimates of the population-level RSV disease burden and insights into the economic value drivers for RSV vaccination," said researchers. 
"Our analysis provides...
07/24/2023
First Report Managed Care
News
Hospital-Onset CDI Incidence, Antibiotic Use Drop With Two-Step Testing
08/16/2023
Jolynn Tumolo
The implementation of two-step testing for Clostridioides difficile infection may lead to a decrease in hospital-onset CDI and antibiotic use, suggesting improved diagnostic specificity and indirect reassurance against underdiagnosis and...
The implementation of two-step testing for Clostridioides difficile infection may lead to a decrease in hospital-onset CDI and antibiotic use, suggesting improved diagnostic specificity and indirect reassurance against underdiagnosis and...
The implementation of two-step...
08/16/2023
First Report Managed Care

June 2017 Volume 14 Issue 6

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use